Gastroenterology
Latest News
Mixed CRC screening messaging. Confusing? Some docs think so
The discordance may confuse patients and lead to varying referral practices among primary care physicians.
News from the FDA/CDC
FDA approves new drug for ulcerative colitis
The approval of etrasimod was based on safety and efficacy data from two randomized, double-blind, placebo-controlled phase 3 trials.
Latest News
AI detects hidden, potentially curable pancreatic cancers
"Artificial intelligence model could mitigate the inadequacies of imaging and the diagnostic errors in interpretation," the authors wrote.
From the Journals
Anti-acid meds lower strength of systemic sclerosis drug
Weakened bioavailability of mycophenolate mofetil could require adjustments in treatment.
Commentary
Take a closer look at sleep’s role in GERD
If GERD is acting as a trigger to sleep disruption, you need to ask your patients with this condition about next-day function.
From the Journals
More evidence shows COVID-19’s link to risk for autoimmune disease
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several...
Feature
The new word in liver disease: The story behind NAFLD’s rebranding as MASLD
“There are tons of these patients who were not being considered before. Now they’re in a category by themselves, where they are going to be able...
Latest News
Jury out on how tea drinking influences colorectal cancer risk
Tea drinking may reduce the risk for colorectal cancer by 24%, but the estimate is uncertain.
From the Journals
Vegetarian diets tied to lower risk for some GI cancers
“The results of this systematic review indicate that adherence to vegetarian diets can reduce the risk of gastrointestinal cancers, compared with...
Latest News
Study finds inflammatory bowel disease risk higher in children, adults with atopic dermatitis
AD has been associated with an increasing number of comorbidities, including IBD, but studies linking AD with IBD have had mixed results,...
News from the FDA/CDC
FDA OKs subcutaneous vedolizumab for UC maintenance therapy
The safety profile of subcutaneous vedolizumab was “generally consistent” with the intravenous form of the drug, with the addition of injection-...